ID
22329
Description
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, This form is to be performed after 2 weeks. Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1
Link
https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1
Keywords
Versions (1)
- 5/30/17 5/30/17 -
Uploaded on
May 30, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Baseline Signs and Symptoms Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
Baseline Signs and Symptoms Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
Description
Baseline Signs and Symptoms
Alias
- UMLS CUI-1
- C0877248
- UMLS CUI-2
- C0037088
Description
Diagnosis
Data type
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0011900
Description
Onset Date and Time
Data type
datetime
Alias
- UMLS CUI [1]
- C2985916
Description
Outcome
Data type
integer
Alias
- UMLS CUI [1]
- C1705586
Description
Course
Data type
integer
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0750729
Description
Episode
Data type
float
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0332189
Description
Intensity
Data type
integer
Alias
- UMLS CUI [1,1]
- C0522510
- UMLS CUI [1,2]
- C0877248
Description
trial procedures
Data type
integer
Alias
- UMLS CUI [1,1]
- C0008976
- UMLS CUI [1,2]
- C2700391
Description
Corrective Therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0087111
Description
Withdrawal
Data type
boolean
Alias
- UMLS CUI [1]
- C2349954
Similar models
Baseline Signs and Symptoms Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
C0037088 (UMLS CUI-2)
C0011900 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,2])
C2700391 (UMLS CUI [1,2])